drugset / Trial / NCT01498926

Comparison of Two Insulin Detemir Formulations in Healthy Volunteers

NCT01498926

Phase 1 Completed 34 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare two formulations of insulin detemir containing an isotonic agent in healthy volunteers.

Timeline

Start
2005-11
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic Subcutaneous

Indications